These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24840101)

  • 1. Benefits of β blockers in chronic obstructive pulmonary disease and heart failure.
    Creagh-Brown B
    BMJ; 2014 May; 348():g3316. PubMed ID: 24840101
    [No Abstract]   [Full Text] [Related]  

  • 2. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
    Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
    J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specialist initiation and monitoring of β blockers in patients with chronic heart failure and concomitant obstructive airways disease.
    Critchley WR; Al-Sheklly B; Sekar B; Coppinger T; Waywell C; Leonard CT; Niven R; Williams SG; Shaw SM
    Int J Cardiol; 2013 Sep; 167(5):2361-3. PubMed ID: 23206521
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Otto CM
    Heart; 2016 Dec; 102(23):1855-1856. PubMed ID: 27836944
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of a community heart failure clinic on uptake of beta blockers by patients with obstructive airways disease and heart failure.
    Shelton RJ; Rigby AS; Cleland JG; Clark AL
    Heart; 2006 Mar; 92(3):331-6. PubMed ID: 15951394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchodilator therapy in acute decompensated heart failure patients without a history of chronic obstructive pulmonary disease.
    Singer AJ; Emerman C; Char DM; Heywood JT; Kirk JD; Hollander JE; Summers R; Lee CC; Wynne J; Kellerman L; Peacock WF
    Ann Emerg Med; 2008 Jan; 51(1):25-34. PubMed ID: 17949853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexisting chronic obstructive pulmonary disease and heart failure: implications for treatment, course and mortality.
    Mascarenhas J; Azevedo A; Bettencourt P
    Curr Opin Pulm Med; 2010 Mar; 16(2):106-11. PubMed ID: 20042977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
    Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
    Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation or maintenance of beta-blocker therapy in patients hospitalized for acute heart failure.
    Passos LC; Oliveira MG; Duraes AR; Trindade TM; Barbosa AC
    Int J Clin Pharm; 2016 Aug; 38(4):802-7. PubMed ID: 27138843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All that wheezes is not obstructive pulmonary disease.
    Cydulka RK
    Ann Emerg Med; 2008 Jan; 51(1):35-6. PubMed ID: 17719693
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease.
    Neef PA; McDonald CF; Burrell LM; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2016 Nov; 46(11):1336-1340. PubMed ID: 27813357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic obstructive pulmonary disease and heart failure].
    Villar Alvarez F; Méndez Bailón M; de Miguel Díez J
    Arch Bronconeumol; 2009 Aug; 45(8):387-93. PubMed ID: 19595494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences among beta-blockers for the treatment of patients with heart failure and chronic obstructive pulmonary disease].
    Di Tano G; Frattini S; Pirelli S
    G Ital Cardiol (Rome); 2011 Sep; 12(9):588-95. PubMed ID: 21892219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of heart failure with beta-receptor-blockers].
    Schwinger RH
    Dtsch Med Wochenschr; 2002 Mar; 127(13):682-8. PubMed ID: 11928060
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart rate-guided, but not dose-guided titration of beta blockers stabilizes ventricular repolarization in patients with chronic heart failure.
    Fister M; Mikuz U; Starc V; Vrtovec B; Haddad F
    J Electrocardiol; 2016; 49(4):579-86. PubMed ID: 26875428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.